Tag Archives: TGACC

TGA provides complementary medicine industry with “Get Out of Jail Free card”

Posted on November 4, 2017 by Dr Ken Harvey

The TGA have recently given approval (under section 42DF of the Therapeutic Goods Act 1989) for a restricted advertising representation by The Tomato Pill Company for Ateronon XY Pro: “Saw Palmetto is traditionally used in herbal medicine to help relieve the … Continue reading →

Posted in Complementary medicine, Natural Therapies, Pharmaceutical Promotion | Tagged , , , , , , , , , , | 1 Comment

TGA Consultation Submissions: Regulatory reform of complementary medicines and advertising

Posted on October 25, 2017 by Dr Ken Harvey

The regulatory framework for advertising therapeutic goods Reforms to the regulatory framework for complementary medicines – assessment pathways Options for the future regulation of “low-risk” products Draft List of Permitted Indications Therapeutic Goods Advertising Code See also: Australian patients vulnerable … Continue reading →

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , | Leave a comment

TGA has lost trust on CMS: Harvey

Posted on November 8, 2016 by Dr Ken Harvey

“a market flooded with shonky products and unethical claims” Open debate needed for TGA to regain trust   TGA has lost trust on CMs: Harvey by

Posted in Complementary medicine, Medicine policy, Natural Therapies, Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment

Bizarre advertising approval by TGA

Posted on August 4, 2016 by Dr Ken Harvey

The TGA can only grant advertising approval for a restricted representation if the representation is accurate, balanced, not misleading and in the public interest. The TGA has now approved restricted representations for two probiotic products: Puremedic Pty Ltd (9 June 2016); … Continue reading →

Posted in Pharmaceutical Promotion | Tagged , , , , , , , , , | Leave a comment

TGA failure gives Nurofen consumers a headache

Posted on August 10, 2012 by Dr Ken Harvey

http://theconversation.edu.au/tga-failure-gives-nurofen-consumers-a-headache-8762 by

Posted in Pharmaceutical Promotion | Tagged , , , | Leave a comment

Complementary Medicine Regulation Reform Suggestions

Posted on June 5, 2011 by Dr Ken Harvey

My submission to the TGA Working Group on Complementary Medicine Regulation Reform as a representative of:     Problem It is alleged that some sponsors are not aware of the regulatory issues concerning complementary medicines including the Therapeutic Goods Advertising … Continue reading →

Posted in Complementary medicine | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment